Cetrizine di hcl

Cetrizine di hcl
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrizine di hcl. It belongs toantiallergic apis category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg

    Product Ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.
  • Ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

    Product Ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us fo...
  • Ceftiofur sodium sterile & ceftiofur hcl

    Product Ceftiofur sodium sterile & ceftiofur hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftiofur sodium sterile & ceftiofur hcl. It belongs to cephalosporins apis products category. Contact us for more information.
  • Ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg

    Product Ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Cont...
  • Ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg

    Product Ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg. It belobgs to antibacterial cephalosporins finish formulations products c...
  • Certrorelix acetate injection (0.25 / vial)

    Product Certrorelix acetate injection (0.25 / vial)

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes certrorelix acetate injection (0.25 / vial). It belongs to gynaecology finish formulations products category. Contact us for more information.
  • Cetrorelix acetate

    Product Cetrorelix acetate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrorelix acetate. It belongs to infertility apis category. Contact us for more information.
  • Cetuximab

    Product Cetuximab

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetuximab. It belongs to monoclonal antibodies apis category. Contact us for more information.
  • Choline alfoscerate

    Product Choline alfoscerate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate. It belongs to antialzheimer apis category. Contact us for more information.
  • Choline alfoscerate 400 mg soft caps & 250 mg/ml injection

    Product Choline alfoscerate 400 mg soft caps & 250 mg/ml injection

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate 400 mg soft caps & 250 mg/ml injection. It belongs to central nervous system finish formulations products category. Contact us for more information.
  • Cisplatin injection 10 mg/ 50 mg

    Product Cisplatin injection 10 mg/ 50 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cisplatin injection 10 mg/ 50 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.
  • Citalopram hydrobromide

    Product Citalopram hydrobromide

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citalopram hydrobromide. It belongs to antideperessant apis category. Contact us for more information.
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)